Westfield Capital Management
ARRY

Westfield Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Westfield Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-43,000
Closed -$195K – 380
2013
Q2 		$195K Buy
+43,000
New +$231K ﹤0.01% 353

Other funds holding ARRY

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Westfield Capital Management's ARRY Position: Q3 2013 in Review

Westfield Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2013, closing a stake of 43,000 shares — an estimated $195K sold.

Westfield Capital Management first reported a position in ARRY in Q2 2013 and held it in 1 quarter. The position peaked at $195K in Q2 2013. 134 funds tracked by Wall St. Rank hold ARRY as of Q3 2013.

  • Westfield Capital Management reported no remaining Array Biopharma Inc position as of Q3 2013 after selling out during the quarter.
  • Westfield Capital Management sold 43,000 Array Biopharma Inc shares in Q3 2013, an estimated $195K.
  • Westfield Capital Management first reported a position in Array Biopharma Inc in Q2 2013 and held it in 1 quarter.
  • Westfield Capital Management's Array Biopharma Inc position peaked at $195K in Q2 2013.
  • 134 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2013.

Based on Westfield Capital Management's 13F filing for Q3 2013, filed 12 Nov 2013.